Document:

exv10w2

Exhibit 10.2

RESOLUTE ENERGY CORPORATION

STOCK APPRECIATION RIGHT GRANT AGREEMENT

(Non-Employee Directors)

     This Stock Appreciation Right Grant Agreement (this “Agreement”) between RESOLUTE
ENERGY CORPORATION (the “Corporation”) and [                    ] (“Participant”) is dated
effective [                    ] (the “Date of Grant”).

RECITALS

     A. The Corporation has adopted the Resolute Energy Corporation 2009 Performance Incentive Plan
(the “Plan”);

     B. The Plan provides for the granting of stock appreciation rights to eligible persons as
determined by the Administrator;

     C. On                     , the Board determined that directors of the Corporation should receive
compensation for their services from                      through                     , subject to a
determination from legal, tax and compensation advisors regarding the form of such compensation;

     D. Participant
has been a director of the Corporation from                      through
                    , is currently a director of the Corporation and is a person eligible to receive an
award under the Plan; and

     E. The Administrator has determined that Participant should receive compensation under the
Plan in respect of Participant’s service from                      through                      in the form of stock
appreciation rights and has determined that it is in the best interests of the Corporation to grant
the stock appreciation right award provided for herein.

AGREEMENT

1. Grant of Stock Appreciation Rights.

     (a) Stock Appreciation Rights. Pursuant to the Plan, and in consideration of
non-employee director services rendered by Participant to the Corporation, Participant is hereby
awarded stock appreciation rights covering
                 shares of the Corporation’s common stock (the
“Common Stock”), subject to the conditions of the Plan and this Agreement (the “Stock
Appreciation Rights”). A Stock Appreciation Right is a right to receive an amount in cash
equal to the excess, if any, of the Fair Market Value of a share of Common Stock on the date on
which a Stock Appreciation Right is exercised over its Base Price (such amount, the
“Spread”). The base price for the Stock Appreciation Rights granted hereby is $[   ] per
share of Common Stock, which is the Fair Market Value of a share of Common Stock on the Date of
Grant (the “Base Price”).

     (b) Definition of Fair Market Value. For purposes of this Agreement, “Fair Market
Value” shall mean the last sale price for a share of Common Stock as quoted on the New York

 

 

Stock Exchange (“NYSE”) or other principal stock exchange on which the Common Stock is
then listed for the date in question or, if no sales of Common Stock were reported by the NYSE or
other such exchange on that date, the last price for a share of Common Stock as furnished by the
NYSE or other such exchange for the next preceding day on which sales of Common Stock were reported
by the NYSE. If the Common Stock is no longer listed or is no longer actively traded on the NYSE
or listed on a principal stock exchange as of the applicable date, the Fair Market Value of the
Common Stock shall be the value as reasonably determined by the Administrator for purposes of the
award in the circumstances.

     (c) Plan Incorporated. Participant acknowledges receipt of a copy of the Plan, and
agrees that, except as contemplated by Section 13 below, this award of Stock Appreciation
Rights shall be subject to all of the terms and conditions set forth in the Plan, including future
amendments thereto, if any, pursuant to the terms thereof, which Plan is incorporated herein by
reference as a part of this Agreement.

2. Vesting and Forfeiture.

     (a) Vesting Schedule. The Stock Appreciation Rights shall vest pursuant to the
schedule below (each date below upon which vesting occurs pursuant to this Section 2 being
referred to herein as a “Vesting Date”). The Stock Appreciation Rights that have vested in
accordance with this Section 2 are referred to herein in as “Vested SARs.”

	 	 	 

	

Vesting Date
	 	Number of

Stock Appreciation 

Rights Vested
	 
	 	 

     (b) Continuing Provision of Services. Vesting pursuant to the foregoing schedule
shall occur on a Vesting Date only if Participant continues to provide services to the Corporation
from the Date of Grant to such Vesting Date. If Participant ceases to provide services to the
Corporation at any time prior to the final Vesting Date, except as provided below, all unvested
Stock Appreciation Rights shall be forfeited immediately on the date that Participant’s service is
terminated, and Participant shall have no further rights with respect to such unvested Stock
Appreciation Rights.

     (c) Acceleration of Vesting on Death or Disability. Notwithstanding the foregoing,
all unvested Stock Appreciation Rights shall vest effective immediately upon the death of
Participant or upon the Administrator’s determination that Participant has suffered from a
Disability (as defined) and has been removed from or terminated service to the Corporation. For
purposes of this Agreement, “Disability” means a physical or mental infirmity which impairs
Participant’s ability to substantially perform his or her duties as a non-employee director.

     (d) Accelerated Vesting of Stock Appreciation Right. If, when and to the extent
determined by the Administrator pursuant to Section 7.3 of the Plan, in the event that the

2

 

     Corporation undergoes a Change in Control Event, any unvested Stock Appreciation Rights held
by Participant will become fully vested.

3. Exercise.

     (a) Deemed Exercise. Upon vesting of each unvested Stock Appreciation Right pursuant
to Section 2 hereof, each Vested SAR shall be deemed exercised as of the Vesting Date.

     (b) Payment. On the deemed exercise of each Vested SAR, the Corporation shall deliver
to Participant an amount equivalent to the Spread for each Vested SAR in cash, less any amounts
withheld pursuant to Section 5 hereof.

4. Issuance and Limits on Transferability. The Stock Appreciation Rights shall not be
transferable except by will or the laws of descent and distribution or pursuant to a beneficiary
designation, or as otherwise permitted by Section 5.7 of the Plan. No right or benefit hereunder
shall in any manner be liable for or subject to any debts, contracts, liabilities, or torts of
Participant. Any purported assignment, alienation, pledge, attachment, sale, transfer or other
encumbrance of any Stock Appreciation Rights that does not satisfy the requirements of this
Agreement and the Plan shall be void and unenforceable against the Corporation. The Corporation
shall not be required to treat as owner of such Stock Appreciation Right any transferee to whom
such Stock Appreciation Right has been transferred in violation of any of the provisions of this
Agreement.

5. Withholding. In order to comply with all applicable federal or state income tax laws or
regulations, the Corporation may take such action as it deems appropriate to ensure that all
applicable federal or state payroll, withholding, income or other taxes, which are the sole and
absolute responsibility of Participant, are withheld or collected from Participant. In accordance
with the terms of the Plan, and such rules as may be adopted by the Administrator under the Plan,
the Corporation shall have the right to withhold an amount sufficient to satisfy Participant’s
federal and state tax withholding obligations arising from the exercise of the Stock Appreciation
Rights.

6. Tax Matters. The Corporation has advised Participant to seek Participant’s own tax and
financial advice with regard to the federal and state tax considerations resulting from
Participant’s receipt of the Stock Appreciation Rights pursuant to this Agreement. With respect to
applicable tax withholding amounts, if any, the Corporation has all of the rights specified in
Section 5 of this Agreement and has no obligations to Participant except as expressly stated in
Section 5 of this Agreement.

7. Rights as a Stockholder. Neither Participant nor any person claiming under or through
Participant shall be, or have any of the rights or privileges of, a stockholder of the Corporation
with respect to the Stock Appreciation Rights.

8. Termination of Stock Appreciation Rights. Each Stock Appreciation Right and all rights
and privileges thereunder shall terminate and may no longer be exercised upon the earlier to occur
of (i) the forfeiture of the Stock Appreciation Right pursuant to Section 2(b) hereof or
(ii) the deemed exercise of such Stock Appreciation Right pursuant to Section 3 hereof.

3

 

9. Authority of Administrator. In making any decisions or taking any actions with respect
to the matters covered by this Agreement, the Administrator shall have all of the authority and
discretion, and shall be subject to all of the protections, provided for in the Plan. All
decisions and actions by the Administrator with respect to this Agreement, including the
determination of Fair Market Value, shall be made in the Administrator’s discretion and shall be
final and binding on the Participant.

10. Notice. Any notice to be given to the Corporation under the terms of this Agreement
shall be addressed to the Corporation, in care of the Secretary, at 1675 Broadway, Suite 1950,
Denver, Colorado 80202, or at such other address as the Corporation may designate in writing to
Participant. Any notice to be given to Participant shall be addressed to Participant at the
address set forth beneath his signature below, or at any other address as Participant may designate
in writing to the Corporation.

11. Binding Effect. This Agreement shall bind Participant and the Corporation and their
beneficiaries, survivors, executors, administrators and transferees.

12. Applicable Law. This Agreement shall be governed by and construed and enforced in
accordance with the laws of the State of Delaware without regard to conflict of law principles
thereunder.

13. Conflicts and Interpretation. In the event of any conflict between this Agreement and
the Plan, this Agreement shall control. In the event of any ambiguity in this Agreement, or any
matters as to which this Agreement is silent, the Plan shall govern including, without limitation,
the provisions thereof pursuant to which the Administrator has the power, among others, to (i)
interpret the Plan, (ii) prescribe, amend and rescind rules and regulations relating to the Plan
and (iii) make all other determinations deemed necessary or advisable for the administration of the
Plan.

14. Amendment. The Corporation may modify, amend or waive the terms of the Stock
Appreciation Right award, prospectively or retroactively, but no such modification, amendment or
waiver shall impair the rights of Participant without his or her consent, except as required by
applicable law, NYSE or stock exchange rules, tax rules or accounting rules. Prior to the
effectiveness of any modification, amendment or waiver required by tax or accounting rules, the
Corporation will provide notice to Participant and the opportunity for Participant to consult with
the Corporation regarding such modification, amendment or waiver. The waiver by either party of
compliance with any provision of this Agreement shall not operate or be construed as a waiver of
any other provision of this Agreement, or of any subsequent breach by such party of a provision of
this Agreement.

15. Adjustments. If the outstanding Common Stock is increased, decreased, changed into, or
exchanged for a different number or kind of shares or securities through merger, consolidation,
combination, exchange of shares, other reorganization, recapitalization, reclassification, stock
dividend, stock split or reverse stock split and if the Stock Appreciation Rights granted hereunder
do not otherwise vest as a result thereof, an appropriate and proportionate adjustment shall be
made in the number and kind of Stock Appreciation Rights to which Participant shall be entitled
under this Agreement, all in accordance with Section 7 of the Plan.

4

 

16. Defined Terms. All capitalized terms used herein and not otherwise defined herein
shall have the meanings set forth therefor in the Plan.

[Signature Page Follows.]

5

 

     IN WITNESS WHEREOF, the parties have executed this Stock Appreciation Right Grant Agreement as
of the date first written above.

	 	 	 	 	 
	 	RESOLUTE ENERGY CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	PARTICIPANT:

 	 
	 	 	  
	 	[NAME] 	 
	 	[ADDRESS]exv10w13

Exhibit 10.13

INDEMNIFICATION AGREEMENT

     THIS INDEMNIFICATION AGREEMENT (this "Agreement") is entered into as of
the ___ day of _________, _________, by and between SciQuest, Inc., a Delaware corporation
(“SciQuest”), and _________ (“Indemnitee”).

     RECITALS

     A. SciQuest and Indemnitee recognize the continued difficulty in obtaining liability insurance
for its directors, officers, employees, stockholders, controlling persons, agents and fiduciaries,
the significant increases in the cost of such insurance and the general reductions in the coverage
of such insurance.

     B. SciQuest and Indemnitee further recognize the substantial increase in corporate litigation
in general, subjecting directors, officers, employees, controlling persons, stockholders, agents
and fiduciaries to expensive litigation risks at the same time as the availability and coverage of
liability insurance has been severely limited.

     C. Indemnitee does not regard the current protection available as adequate under the present
circumstances, and Indemnitee and other directors, officers, employees, stockholders, controlling
persons, agents and fiduciaries of SciQuest may not be willing to serve in such capacities without
additional protection.

     D. SciQuest (i) desires to attract and retain the involvement of highly qualified individuals
and groups, such as Indemnitee, to serve SciQuest and, in part, in order to induce Indemnitee to be
involved with SciQuest, and (ii) wishes to provide for the indemnification and advancing of
expenses to Indemnitee to the maximum extent permitted by law.

     E. In view of the considerations set forth above, SciQuest desires that Indemnitee be
indemnified by SciQuest as set forth herein.

     NOW THEREFORE, SciQuest and Indemnitee hereby agree as follows:

     1. Indemnification.

          (a) Indemnification of Expenses. SciQuest shall indemnify and hold harmless Indemnitee
(including its respective directors, officers, general partners, limited partners, members,
managing members, employees, agents and spouses, if any) and each person who controls any of them
or who may be liable within the meaning of Section 15 of the Securities Act of 1933, as amended
(the “Securities Act”), or Section 20 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), to the fullest extent permitted by law if Indemnitee was or is or becomes a party
to or witness or other participant in, or is threatened to be made a party to or witness or other
participant in, any threatened, pending or completed

 

 

action, suit, proceeding or alternative dispute resolution mechanism, or any hearing, inquiry
or investigation that Indemnitee believes might lead to the institution of any such action, suit,
proceeding or alternative dispute resolution mechanism, whether civil, criminal, administrative,
investigative or other (hereinafter a “Claim”) by reason of (or arising in part out of) any event
or occurrence related to the fact that Indemnitee is or was or may be deemed a director, officer,
stockholder, employee, controlling person, agent or fiduciary of SciQuest, or any subsidiary of
SciQuest, or is or was or may be deemed to be serving at the request of SciQuest as a director,
officer, stockholder, employee, controlling person, agent or fiduciary of another corporation,
partnership, joint venture, trust or other enterprise, or by reason of any action or inaction on
the part of Indemnitee while serving in such capacity including, without limitation, any and all
losses, claims, damages, expenses and liabilities, joint or several (including any investigation,
legal and other expenses incurred in connection with, and any amount paid in settlement of, any
action, suit, proceeding or any claim asserted) under the Securities Act, the Exchange Act or other
federal or state statutory law or regulation, at common law or otherwise, which relate directly or
indirectly to the registration, purchase, sale or ownership of any securities of SciQuest or to any
fiduciary obligation owed with respect thereto or as a result of any claim (i) made by any
stockholder of SciQuest against Indemnitee and arising out of or related to any round of financing
of SciQuest, including, but not limited to, claims regarding participation, non-participation, or
non-pro rata participation, in such round by such stockholder or by Indemnitee or any affiliated or
related entity, (ii) made by a third party against Indemnitee based on any misstatement or omission
of a material fact by SciQuest in violation of any duty of disclosure imposed on SciQuest by
federal or state securities or common laws, (iii) made by a third party against Indemnitee based
(in whole or in part) on, or arising in any way out of, or relating to conduct attributed to
SciQuest or anyone alleged to be acting on SciQuest’s behalf, or (iv) made by a third party against
Indemnitee based (in whole or in part) on, or arising in any way out of, or relating to (A)
Indemnitee being an investor in SciQuest, (B) Indemnitee’s alleged participation in the management
or direction of SciQuest, (C) Indemnitee’s alleged participation in providing any assistance or
advice to SciQuest, or (D) Indemnitee being a person described in Section 15 of the Securities Act
or Section 20 of the Exchange Act (hereinafter individually an “Indemnification Event” and
collectively the “Indemnification Events”) against any and all expenses (including attorneys fees
and all other costs, expenses and obligations incurred in connection with investigating, defending,
being a witness in or participating in (including an appeal), or preparing to defend, be a witness
in or participate in, any such action, suit, proceeding, alternative dispute resolution mechanism,
hearing, inquiry or investigation), judgments, fines, penalties and amounts paid in settlement (if,
and only if, such settlement is approved in advance by SciQuest, which approval shall not be
unreasonably withheld) of such Claim and any federal, state, local or foreign taxes imposed on
Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement
(collectively, hereinafter “Expenses”), including all interest, assessments and other charges paid
or payable in connection with or in respect of such Expenses. Such payment of Expenses shall be
made by SciQuest as soon as practicable but in any event no later than ten (10) days after written
demand by the Indemnitee therefor is presented to SciQuest.

          (b) Reviewing Party. Notwithstanding the foregoing, (i) the obligations of SciQuest under
Section 1(a) shall be subject to the condition that it shall not have been

2

 

finally determined that Indemnitee would not be permitted to be indemnified under applicable
law (initial determination shall be made by the Reviewing Party as defined in Section 9(f) hereof
in a written opinion, in any case in which the Independent Legal Counsel as defined in Section 9(e)
hereof and referred to in Section 1(e) hereof is involved), and (ii) Indemnitee acknowledges and
agrees that the obligation of SciQuest to make an advance payment of Expenses to Indemnitee
pursuant to Section 2(a) (an “Expense Advance”) shall be subject to the condition that, if, when
and to the extent that it is so determined that Indemnitee would not be permitted to be so
indemnified under applicable law, SciQuest shall be entitled to be reimbursed by Indemnitee (who
hereby agrees to reimburse SciQuest) for all such amounts theretofore paid; provided, however, that
if Indemnitee has commenced or thereafter commences legal proceedings in a court of competent
jurisdiction to secure a determination that Indemnitee should be indemnified under applicable law,
any initial determination made by the Reviewing Party that Indemnitee would not be permitted to be
indemnified under applicable law shall not be binding and Indemnitee shall not be required to
reimburse SciQuest for any Expense Advance until a final judicial determination is made with
respect thereto (as to which all rights of appeal therefrom have been exhausted or have lapsed).
Indemnitee’s obligation to reimburse SciQuest for any Expense Advance shall be unsecured and no
interest shall be charged thereon. If there has not been a Change in Control (as defined in Section
9(d) hereof), the Reviewing Party shall be selected by the Board of Directors, and if there has
been such a Change in Control (other than a Change in Control which has been approved by a majority
of the Board of Directors who were directors immediately prior to such Change in Control), the
Reviewing Party shall be the Independent Legal Counsel referred to in Section 1(e) hereof. If there
has been no determination by the Reviewing Party or if the Reviewing Party determines that
Indemnitee substantively would not be permitted to be indemnified in whole or in part under
applicable law, Indemnitee shall have the right to commence litigation seeking an initial
determination by the court or challenging any such determination by the Reviewing Party or any
aspect thereof, including the legal or factual bases therefor, and SciQuest hereby consents to
service of process and to appear in any such proceeding. Any determination by the Reviewing Party
otherwise shall be conclusive and binding on SciQuest and Indemnitee.

          (c) Contribution. If the indemnification provided for in Section 1(a) above for any reason is
held by a court of competent jurisdiction to be unavailable to Indemnitee in respect of any losses,
claims, damages, expenses or liabilities referred to therein, then SciQuest, in lieu of
indemnifying Indemnitee thereunder, shall contribute to the amount paid or payable by Indemnitee as
a result of such losses, claims, damages, expenses or liabilities (i) in such proportion as is
appropriate to reflect the relative benefits received by SciQuest and Indemnitee, or (ii) if the
allocation provided by clause (i) above is not permitted by applicable law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in clause (i) above but also
the relative fault of SciQuest and Indemnitee in connection with the action or inaction which
resulted in such losses, claims, damages, expenses or liabilities, as well as any other relevant
equitable considerations. In connection with the registration of SciQuest’s securities, the
relative benefits received by SciQuest and Indemnitee shall be deemed to be in the same respective
proportions that the net proceeds from the offering (before deducting expenses) received by
SciQuest and Indemnitee, in each case as set forth in the table on the cover page of the applicable
prospectus, bear to the aggregate public offering price of the securities so offered. The relative
fault of SciQuest and the Indemnitee shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or

3

 

alleged omission to state a material fact relates to information supplied by SciQuest or
Indemnitee and the parties relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission. SciQuest and Indemnitee agree that it would not be
just and equitable if contribution pursuant to this Section 1(c) were determined by pro rata or per
capita allocation or by any other method of allocation which does not take account of the equitable
considerations referred to in the immediately preceding paragraph. In connection with the
registration of SciQuest’s securities, in no event shall Indemnitee be required to contribute any
amount under this Section 1(c) in excess of the lesser of (i) that proportion of the total of such
losses, claims, damages or liabilities indemnified against equal to the proportion of the total
securities sold under such registration statement which is being sold by Indemnitee or (ii) the
proceeds received by Indemnitee from its sale of securities under such registration statement. No
person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any person who was not found guilty of such
fraudulent misrepresentation.

          (d) Survival Regardless of Investigation. The indemnification and contribution provided for in
this Section 1 will remain in full force and effect regardless of any investigation made by or on
behalf of Indemnitee or any officer, director, general partner, limited partner, member, managing
member, employee, agent or controlling person of Indemnitee.

          (e) Change in Control. SciQuest agrees that if there is a Change in Control of SciQuest (other
than a Change in Control which has been approved by a majority of the Board of Directors who were
directors immediately prior to such Change in Control) then, with respect to all matters thereafter
arising concerning the rights of Indemnitee to payments of Expenses
or an Expense Advance under this
Agreement or any other agreement or under the Certificate or Bylaws as now or hereafter in effect,
Independent Legal Counsel (as defined in Section 9(e) hereof) shall be selected by Indemnitee and
approved by SciQuest (which approval shall not be unreasonably withheld). Such counsel, among other
things, shall render its written opinion to SciQuest and Indemnitee as to whether and to what
extent Indemnitee would be permitted to be indemnified under applicable law. SciQuest agrees to
abide by such opinion and to pay the reasonable fees of the Independent Legal Counsel referred to
above and to fully indemnify such counsel against any and all expenses (including attorneys fees),
claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.

          (f) Mandatory Payment of Expenses. Notwithstanding any other provision of this Agreement, to
the extent that Indemnitee has been successful on the merits or otherwise, including, without
limitation, the dismissal of an action without prejudice, in the defense of any action, suit,
proceeding, inquiry or investigation referred to in Section 1(a) hereof or in the defense of any
claim, issue or matter therein, Indemnitee shall be indemnified against all Expenses incurred by
Indemnitee in connection herewith.

     2. Expenses; Indemnification Procedure.

          (a) Advancement of Expenses. SciQuest shall advance all Expenses incurred by Indemnitee. The
advances to be made hereunder shall be paid by SciQuest to Indemnitee

4

 

as soon as practicable but in any event no later than fifteen (15) days after written demand
by Indemnitee therefor to SciQuest.

          (b) Notice/Cooperation by Indemnitee. Indemnitee shall give SciQuest notice as soon as
practicable of any Claim made against Indemnitee for which indemnification will or could be sought
under this Agreement. Notice to SciQuest shall be directed to the Chief Executive Officer of
SciQuest at the address shown on the signature page of this Agreement (or such other address as
SciQuest shall designate in writing to Indemnitee).

          (c) No Presumptions; Burden of Proof. For purposes of this Agreement, the termination of any
Claim by judgment, order, settlement (whether with or without court approval) or conviction, or
upon a plea of nolo contendere, or its equivalent, shall not create a presumption that Indemnitee
did not meet any particular standard of conduct or have any particular belief or that a court has
determined that indemnification is not permitted by applicable law. In addition, neither the
failure of the Reviewing Party or the Independent Legal Counsel to have made a determination as to
whether Indemnitee has met any particular standard of conduct or had any particular belief, nor an
actual determination by the Reviewing Party or the Independent Legal Counsel that Indemnitee has
not met such standard of conduct or did not have such belief, prior to the commencement of legal
proceedings by Indemnitee to secure a judicial determination, that Indemnitee should be
indemnified under applicable law, shall be a defense to Indemnitee’s claim or create a presumption
that Indemnitee has not met any particular standard of conduct or did not have any particular
belief. In connection with any determination by the Reviewing Party, Independent Legal Counsel or
otherwise as to whether Indemnitee is entitled to be indemnified hereunder, the burden of proof
shall be on SciQuest, as the case may be, to establish that Indemnitee is not so entitled.

          (d) Notice to Insurers. If, at the time of the receipt by SciQuest of a notice of a Claim
pursuant to Section 2(b) hereof, SciQuest has liability insurance in effect which may cover such
Claim, SciQuest shall give prompt written notice of the commencement of such Claim to the insurers
in accordance with the procedures set forth in each of the policies. SciQuest shall thereafter take
all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all
amounts payable as a result of such action, suit, proceeding, inquiry or investigation in
accordance with the terms of such policies.

          (e) Selection of Counsel. In the event SciQuest shall be obligated hereunder to pay the
Expenses or Expense Advance of any Claim, SciQuest shall be entitled to assume the defense of such
Claim, with counsel reasonably approved by Indemnitee, upon the delivery to Indemnitee of written
notice of its election to do so. After delivery of such notice, approval of such counsel by
Indemnitee and the retention of such counsel by SciQuest, SciQuest will not be liable to Indemnitee
under this Agreement for any fees of counsel subsequently incurred by Indemnitee with respect to
the same Claim; provided that, (i) Indemnitee shall have the right to employ Indemnitee’s own
counsel in any such Claim at Indemnitee’s expense; (ii) Indemnitee shall have the right to employ
Indemnitee’s own

5

 

counsel in connection with any such proceeding, at the expense of SciQuest, if such counsel
serves in a review, observer, advice and counseling capacity and does not otherwise materially
control or participate in the defense of such proceeding; and (iii) if either (A) the employment of
counsel by Indemnitee has been previously authorized by SciQuest, (B) Indemnitee shall have
reasonably concluded that there is a conflict of interest between SciQuest and Indemnitee in the
conduct of any such defense, or (C) SciQuest shall not continue to retain such counsel to defend
such Claim, then the fees and expenses of Indemnitee’s counsel shall be at the expense of SciQuest.

     3. Additional Indemnification Rights; Nonexclusivity.

          (a) Scope. SciQuest hereby agrees to indemnify Indemnitee to the fullest extent permitted by
law, even if such indemnification is not specifically authorized by the other provisions of this
Agreement or any other agreement, SciQuest’s Certificate, its Bylaws, or by statute. In the event
of any change after the date of this Agreement in any applicable law, statute or rule which
expands the right of a Delaware corporation to indemnify a member of its board of directors or an
officer, stockholder, employee, controlling person, agent or fiduciary, it is the intent of the
parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits afforded by such
change. In the event of any change in any applicable law, statute or rule which narrows the right
of a Delaware corporation to indemnify a member of its board of directors or an officer,
stockholder, employee, agent or fiduciary, such change, to the extent not otherwise required by
such law, statute or rule to be applied to this Agreement, shall have no effect on this Agreement
or the parties’ rights and obligations hereunder. SciQuest and Indemnitee acknowledge that in
certain instances, federal law or applicable public policy may prohibit SciQuest from indemnifying
its directors, officers, stockholders, employees, controlling persons, agents or fiduciaries under
this Agreement or otherwise.

          (b) Nonexclusivity. The indemnification provided by this Agreement shall be in addition to any
rights to which Indemnitee may be entitled under SciQuest’s Certificate, its Bylaws, any agreement,
any vote of stockholders or disinterested directors, the laws of the State of California or the
State of Delaware, or otherwise. The indemnification provided under this Agreement shall continue
as to Indemnitee for any action Indemnitee took or did not take while serving in an indemnified
capacity even though Indemnitee may have ceased to serve in such capacity, and such indemnification
shall inure to the benefit of Indemnitee from and after Indemnitee’s first day of service as a
director or officer with SciQuest or affiliation with a director or officer from and after the date
such director or officer commences services as a director or officer with SciQuest.

     4. No Duplication of Payments. SciQuest shall not be liable under this Agreement to make any
payment in connection with any Claim made against Indemnitee to the extent Indemnitee has otherwise
actually received payment (under any insurance policy, the Certificate, the Bylaws or otherwise) of
the amounts otherwise indemnifiable hereunder.

     5. Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to
indemnification by SciQuest for any portion of Expenses incurred in connection with any Claim, but
not, however, for all of the total amount thereof, SciQuest

6

 

shall nevertheless indemnify Indemnitee for the portion of such Expenses to which such
Indemnitee is entitled.

     6. Liability Insurance. To the extent SciQuest maintains liability insurance applicable to
directors, officers, stockholders, employees, controlling persons, agents or fiduciaries,
Indemnitee shall be covered by such policies in such a manner as to provide Indemnitee the same
rights and benefits as are accorded to the most favorably insured of SciQuest’s directors, if such
Indemnitee is a director, or of SciQuest’s officers, if such Indemnitee is not a director of
SciQuest but is an officer, or of SciQuest’s key employees, controlling persons, agents or
fiduciaries, if Indemnitee is not an officer or director but is a key employee, agent, controlling
person, or fiduciary.

     7. Exceptions. Notwithstanding any other provision herein to the contrary, SciQuest shall not
be obligated pursuant to the terms of this Agreement:

          (a) Claims Initiated by Indemnitee. To indemnify or advance expenses to Indemnitee with
respect to Claims initiated or brought voluntarily by Indemnitee and not by way of defense, except
(i) with respect to actions or proceedings to establish or enforce a right to indemnification under
this Agreement or any other agreement or insurance policy or under the Certificate or Bylaws now or
hereafter in effect relating to Claims for Indemnifiable Events, (ii) in specific cases if the
Board of Directors has approved the initiation or bringing of such Claim, or (iii) as otherwise
required under Delaware statute or law, regardless of whether Indemnitee ultimately is determined
to be entitled to such indemnification, advance expense payment or insurance recovery, as the case
may be; or

          (b) Claim Under Section 16(b). To indemnify Indemnitee for expenses and the payment of profits
arising from the purchase and sale by Indemnitee of securities in violation of Section 16(b) of the
Exchange Act or any similar successor statute; or

          (c) Unlawful Indemnification. To indemnify an Indemnitee if a final decision by a court having
jurisdiction in the matter shall determine that such indemnification is not lawful.

     8. Period of Limitations. No legal action shall be brought and no cause of action shall be
asserted by or in the right of SciQuest against Indemnitee, Indemnitee’s estate, spouse, heirs,
executors or personal or legal representatives after the expiration of five (5) years from the date
of accrual of such cause of action, and any claim or cause of action of SciQuest shall be
extinguished and deemed released unless asserted by the timely filing of a legal action within such
five (5) year period; provided, however, that if any shorter period of limitations is otherwise
applicable to any such cause of action, such shorter period shall govern.

     9. Construction of Certain Phrases.

          (a) For purposes of this Agreement, references to the “Board of Directors” shall mean the
Board of Directors of SciQuest.

          (b) For purposes of this Agreement, references to “SciQuest” shall include, in

7

 

addition to the resulting corporation, any constituent corporation (including any constituent
of a constituent) absorbed in a consolidation or merger which, if its separate existence had
continued, would have had power and authority to indemnify its directors, officers, stockholders,
employees, agents or fiduciaries, so that if Indemnitee is or was or may be deemed a director,
officer, stockholder, employee, agent, controlling person, or fiduciary of such constituent
corporation, or is or was or may be deemed to be serving at the request of such constituent
corporation as a director, officer, stockholder, employee, controlling person, agent or fiduciary
of another corporation, partnership, joint venture, employee benefit plan, trust or other
enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with
respect to the resulting or surviving corporation as Indemnitee would have with respect to such
constituent corporation if its separate existence had continued.

          (c) For purposes of this Agreement, references to “other enterprises” shall include employee
benefit plans; references to “fines” shall include any excise taxes assessed on Indemnitee with
respect to an employee benefit plan; and references to “serving at the request of SciQuest” shall
include any service as a director, officer, stockholder, employee, agent or fiduciary of SciQuest
which imposes duties on, or involves services by, such director, officer, stockholder, employee,
agent or fiduciary with respect to an employee benefit plan, its participants or its beneficiaries;
and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the
interest of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be
deemed to have acted in a manner “not opposed to the best interests of SciQuest” as referred to in
this Agreement.

          (d) For purposes of this Agreement a “Change in Control” shall be deemed to have occurred if
(i) any “person” (as such term is used in Section 13(d)(3) and 14(d)(2) of the Exchange Act), other
than a trustee or other fiduciary holding securities under an employee benefit plan of SciQuest or
a corporation owned directly or indirectly by the stockholders of SciQuest in substantially the
same proportions as their ownership of stock of SciQuest, (A) who is or becomes the “beneficial
owner” (as defined in Rule 13d-3 under said Exchange Act), directly or indirectly, of securities of
SciQuest representing twenty percent (20%) or more of the combined voting power of the SciQuest’s
then outstanding Voting Securities, increases its beneficial ownership of such securities by five
percent (5%) or more over the percentage so owned by such person, or (B) becomes the “beneficial
owner” (as defined in Rule 13d-3 under said Exchange Act), directly or indirectly, of securities of
SciQuest representing more than thirty percent (30%) of the total voting power represented by the
SciQuest’s then outstanding Voting Securities, (ii) during any period of two (2) consecutive years,
individuals who at the beginning of such period constitute the Board of Directors of SciQuest and
any new director whose election by the Board of Directors or combination for election by SciQuest’s
stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in
office who either were directors at the beginning of the period or whose election or nomination for
election was previously so approved, cease for any reason to constitute a majority thereof, or
(iii) the stockholders of SciQuest approve a merger or consolidation of SciQuest with any other
corporation other than a merger or consolidation which would result in the Voting Securities of
SciQuest outstanding immediately prior thereto continuing to represent (either by remaining
outstanding or by being converted into Voting Securities of the surviving entity) at least
two-thirds (2/3) of the total voting power represented by the Voting Securities of SciQuest or such
surviving entity

8

 

outstanding immediately after such merger or consolidation, or the stockholders of SciQuest
approve a plan of complete liquidation of SciQuest or an agreement for the sale or disposition by
SciQuest of (in one transaction or a series of transactions) all or substantially all of SciQuest’s
assets.

          (e) For purposes of this Agreement, "Independent Legal Counsel” shall mean an
attorney or firm of attorneys, selected in accordance with the provisions of Section 1(e) hereof,
who shall not have otherwise performed services for SciQuest or Indemnitee within the last three
(3) years (other than with respect to matters concerning the right of Indemnitee under this
Agreement, or of other indemnitees under similar indemnity agreements).

          (f) For purposes of this Agreement, a “Reviewing Party” shall mean any appropriate person or
body consisting of a member or members of the Board of Directors or any other person or body
appointed by the Board of Directors who is not a party to the particular Claim for which Indemnitee
is seeking indemnification or Independent Legal Counsel.

          (g) For purposes of this Agreement, “Voting Securities” shall mean any securities of SciQuest
that vote generally in the election of directors.

          (h) For purposes of this Agreement, “stockholder” shall include any holder of any capital
stock of SciQuest and an affiliate thereof.

          (i) For purposes of this Agreement, “affiliate” shall include any limited partner, general
partner, or any member or managing member of such general partner.

          (j) For purposes of this Agreement, “Certificate” shall mean the Certificate of Incorporation
of SciQuest, as amended and/or restated, and in effect from time to time.

     10. Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall constitute an original.

     11. Binding Effect; Successors and Assigns. This Agreement shall be binding upon and inure to
the benefit of and be enforceable by the parties hereto and their respective successors, assigns,
including any direct or indirect successor by purchase, merger, consolidation or otherwise to all
or substantially all of the business and/or assets of SciQuest, partnership, spouses, heirs, and
personal and legal representatives. SciQuest shall require and cause any successor (whether direct
or indirect by purchase, merger, consolidation or otherwise) to all, substantially all, or a
substantial part, of the business and/or assets of SciQuest, by written agreement in form and
substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in
the same manner and to the same extent that SciQuest would be required to perform if no such
succession had taken place. This Agreement shall continue in effect with respect to Claims relating
to Indemnifiable Events regardless of whether Indemnitee continues to serve as a director, officer,
employee, agent, controlling person, or fiduciary of SciQuest or of any other enterprise, including
subsidiaries of SciQuest, at SciQuest’s request.

9

 

     12. Attorneys Fees. In the event that any action is instituted by Indemnitee under this
Agreement or under any liability insurance policies maintained by SciQuest to enforce or interpret
any of the terms hereof or thereof, Indemnitee shall be entitled to be paid all Expenses incurred
by Indemnitee with respect to such action, regardless of whether Indemnitee is ultimately
successful in such action, and shall be entitled to the advancement of Expenses with respect to
such action, unless, as a part of such action, a court of competent jurisdiction over such action
determines that each of the material assertions made by Indemnitee as a basis for such action was
not made in good faith or was frivolous. In the event of an action instituted by or in the name of
SciQuest under this Agreement to enforce or interpret any of the terms of this Agreement,
Indemnitee shall be entitled to be paid all Expenses incurred by Indemnitee in defense of such
action (including costs and expenses incurred with respect to Indemnitee counterclaims and
cross-claims made in such action), and shall be entitled to the advancement of Expenses with
respect to such action.

     13. Notice. All notices and other communications required or permitted hereunder shall be in
writing; shall be effective when given, and shall in any event be deemed to be given (a) five (5)
days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by
first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one business day
after the business day of deposit with federal Express or similar overnight courier, freight
prepaid, or (d) one day after the business day of delivery by facsimile transmission, if
deliverable by facsimile transmission, with copy by first class mail, postage prepaid, and shall be
addressed, if to Indemnitee, to Indemnitee’s address as shown in the records of SciQuest, and, if
to SciQuest, at the address of its principal corporate offices (attention: corporate secretary), or
at such other address as such party may designate by ten (10) days advance written notice to the
other parties hereto.

     14. Consent to Jurisdiction. SciQuest and Indemnitee hereby irrevocably consent to the
jurisdiction and venue of the courts of the State of Delaware for all purposes in connection with
any action or proceeding which arises out of or relates to this Agreement and agree that any action
instituted under this Agreement shall be commenced, prosecuted and continued only in the courts of
the State of Delaware.

     15. Severability. The provisions of this Agreement shall be severable in the event that any of
the provisions hereof (including any provision within a single section, paragraph or sentence) are
held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, and the
remaining provisions shall remain enforceable to the fullest extent permitted by law. Furthermore,
to the fullest extent possible, the provisions of this Agreement (including, without limitations,
each portion of this Agreement containing any provision held to be invalid, void or otherwise
unenforceable, that is not itself invalid, void or unenforceable) shall be construed so as to give
effect to the extent manifested by the provision held invalid, illegal or unenforceable.

     16. Choice of Law. This Agreement shall be governed by and its provisions construed and
enforced in accordance with the laws of the State of Delaware, as applied to contracts between
Delaware residents, entered into and to be performed entirely within the State of Delaware, without
regard to the conflict of laws principles thereof.

10

 

     17. Subrogation. In the event of payment under this Agreement, SciQuest shall be subrogated to
the extent of such payment to all of the rights of recovery of Indemnitee who shall execute all
documents required and shall do all acts that may be necessary to secure such rights and to enable
SciQuest effectively to bring suit to enforce such rights.

     18. Amendment and Termination. No amendment, modification, termination or cancellation of this
Agreement shall be effective unless it is in writing signed by the parties to be bound thereby.
Notice of same shall be provided to all parties hereto. No waiver of any of the provisions of this
Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or
not similar) nor shall such waiver constitute a continuing waiver.

     19. No Construction as Employment Agreement. Nothing contained in this Agreement shall be
construed as giving Indemnitee any right to be retained in the employ of SciQuest or any of its
subsidiaries.

     20. Corporate Authority. The Board of Directors of SciQuest has approved the terms of this
Agreement in accordance with Delaware law.

(THIS SPACE INTENTIONALLY LEFT BLANK)

11

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and
year first above written.

	 	 	 	 	 
	 	SCIQUEST, INC.

 	 
	 	By:  	 	 
	 	 	Stephen J. Wiehe 	 
	 	 	President and Chief Executive Officer 	 
	 	 	 	 
	 	 	Address: 	6501 Weston Parkway, Suite 200  	 
	 	 	 	Cary, North Carolina 27513 	 
	 

AGREED TO AND ACCEPTED:

“Indemnitee”

_________________________

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]